[1]
A. Müller, “Clinical-ophthalmological characteristics and evolution of patients with moderately severe active thyroid ophthalmopathy treated with methylprednisolone boluses who attended the Central Hospital of the Instituto de Previsión Social, Paraguay”, ANALES, vol. 56, no. 3, pp. 58–66, Dec. 2023.